PATENT CLAIM ANALYSIS

Application Number: 16355352
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "263200"]

Abstract:
The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R 1 , R 4  and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

Claim (Index 15):
The compound of  claim 1 , wherein R 4  is: wherein:\n each R 10  is independently: H; halogen; \u2014CN; \u2014OH; C 1-4  alkyl; substituted or unsubstituted C 3-6  cycloalkyl; C 1-4  haloalkyl; C 1-4  haloalkoxy; C 1-4  alkoxy; \u2014SO 2 \u2014C 1-4  alkyl; C 1-4  CN; C 1-4  aldehyde; C 1-4  ketone; \u2014S\u2014C 1-4  haloalkyl; substituted or unsubstituted 5- to 6-membered heteroaryl; substituted or unsubstituted 4- to 6-membered hetercycloalkyl; or substituted or unsubstituted C 5-6  aryl; and \n each u is independently 0, 1, 2 or 3.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 99.0
- Lexical Diversity: 1.56
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14118113', '16033632', '15298686', '15459141', '15945852']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8083029847159945
- 35 USC 102 Novelty (BERT): 0.5188109154623947
- Combined Prediction Score: 0.7793537777906345
- Mean Citation Score: 320.109122
- Max Citation Score: 323.93375
- Similarity Product: 261.3149204804003

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test